The global molecular diagnostics in infectious disease testing market, valued at US$ 57 billion in 2024, is projected to reach an estimated US$ 83 billion by 2031.
This product will be delivered within 1-3 business days.
Market Overview
Molecular diagnostics in infectious disease testing involves the detection of genetic materials and proteins associated with specific health conditions and infectious agents in body fluids. Hospitals, academic institutions, laboratories, and others widely use this technique. The market is driven by an increasing number of infectious diseases, technological advancements in diagnostic technologies, and government support for disease diagnosis and prevention. However, high instrument costs and a shortage of skilled healthcare professionals present challenges.Factors Driving Market Growth
- High Incidence of Infectious Diseases Worldwide: The prevalence of infectious diseases like influenza, COVID-19, HIV, hospital-acquired infections (HAIs), and hepatitis, coupled with the need for point-of-care diagnostics, is expected to drive market growth.
- Expanding Geriatric Population: The global geriatric population is expanding, making them more vulnerable to infectious diseases like COVID-19. Regular testing to prevent severe illnesses presents growth opportunities, especially in countries with aging populations.
- Polymerase Chain Reaction (PCR) Segment Leading: The PCR segment is expected to dominate the market, owing to its traditional use in infectious disease diagnosis and advancements in technology, including high-throughput PCR for coronavirus detection.
Regional Dominance
North America is set to lead the global molecular diagnostics in infectious disease testing market, driven by regulatory support, increased investment in diagnostics, growing demand for molecular testing, and the early diagnosis of infections in patients with underlying medical conditions. The prevalence of drug-resistant infections further contributes to the region's market growth.Key Market Players
Major companies in the global molecular diagnostics in infectious disease testing market include Abbott Laboratories, Becton, Dickinson and Company, bioMérieux, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Siemens AG, Veridex, LLC, Luminex Corp., GenMark Diagnostics, Inc., Qiagen N.V., Genomix Biotech, and bioTheranostics.Molecular Diagnostics in Infectious Disease Testing Industry Research Segmentation
By Product:
- Instruments and Analyzers
- Assays and Reagents
- Services and Software
By Application:
- Hepatitis B
- Hepatitis C
- AIDS
- Tuberculosis
- Methicillin-Resistant Staphylococcus Aureus (MRSA)
- Hospital-Acquired Infections
- Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
- Human Papillomavirus (HPV) Infection
- Others
By Technique:
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Microarrays
- Next-Generation Sequencing (NGS)
- Hybridization
- Others
By End User:
- Hospitals
- Private Labs
- Clinics
- Academic Institutes
- Laboratories
- Others
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
1.1. Global Molecular Diagnostics in Infectious Disease Testing Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Production Output and Trade Statistics, 2018 - 2023
3.1. Global Molecular Diagnostics in Infectious Disease Testing Market Production Output, by Region, Value (US$ Bn) and Volume (Million Units), 2018 - 2023
3.1.1. North America
3.1.2. Europe
3.1.3. Asia Pacific
3.1.4. Latin America
3.1.5. Middle East and Africa
3.1.1. North America
3.1.2. Europe
3.1.3. Asia Pacific
3.1.4. Latin America
3.1.5. Middle East and Africa
4. Price Analysis, 2018 - 2023
4.1. Global Average Price Analysis, by Product, US$ Per Unit, 2018 - 2023
4.2. Prominent Factor Affecting Molecular Diagnostics in Infectious Disease Testing Prices
4.3. Global Average Price Analysis, by Region, US$ Per Unit
4.2. Prominent Factor Affecting Molecular Diagnostics in Infectious Disease Testing Prices
4.3. Global Average Price Analysis, by Region, US$ Per Unit
5. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook, 2018 - 2031
5.1. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Instruments and Analyzers
5.1.1.2. Assays and Reagents
5.1.1.3. Services and Software
5.2. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Hepatitis B
5.2.1.2. Hepatitis C
5.2.1.3. AIDS
5.2.1.4. Tuberculosis
5.2.1.5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
5.2.1.6. Hospital-Acquired Infections
5.2.1.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
5.2.1.8. Human Papillomavirus (HPV) Infection
5.2.1.9. Others
5.3. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Polymerase Chain Reaction (PCR)
5.3.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
5.3.1.3. Microarrays
5.3.1.4. Next-Generation Sequencing (NGS)
5.3.1.5. Hybridization
5.3.1.6. Others
5.4. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Hospitals
5.4.1.2. Private Labs
5.4.1.3. Clinics
5.4.1.4. Academic Institutes
5.4.1.5. Laboratories
5.4.1.6. Others
5.5. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1. Key Highlights
5.5.1.1. North America
5.5.1.2. Europe
5.5.1.3. Asia Pacific
5.5.1.4. Latin America
5.5.1.5. Middle East & Africa
5.1.1. Key Highlights
5.1.1.1. Instruments and Analyzers
5.1.1.2. Assays and Reagents
5.1.1.3. Services and Software
5.2. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Hepatitis B
5.2.1.2. Hepatitis C
5.2.1.3. AIDS
5.2.1.4. Tuberculosis
5.2.1.5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
5.2.1.6. Hospital-Acquired Infections
5.2.1.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
5.2.1.8. Human Papillomavirus (HPV) Infection
5.2.1.9. Others
5.3. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Polymerase Chain Reaction (PCR)
5.3.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
5.3.1.3. Microarrays
5.3.1.4. Next-Generation Sequencing (NGS)
5.3.1.5. Hybridization
5.3.1.6. Others
5.4. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Hospitals
5.4.1.2. Private Labs
5.4.1.3. Clinics
5.4.1.4. Academic Institutes
5.4.1.5. Laboratories
5.4.1.6. Others
5.5. Global Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
5.5.1. Key Highlights
5.5.1.1. North America
5.5.1.2. Europe
5.5.1.3. Asia Pacific
5.5.1.4. Latin America
5.5.1.5. Middle East & Africa
6. North America Molecular Diagnostics in Infectious Disease Testing Market Outlook, 2018 - 2031
6.1. North America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Instruments and Analyzers
6.1.1.2. Assays and Reagents
6.1.1.3. Services and Software
6.2. North America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Hepatitis B
6.2.1.2. Hepatitis C
6.2.1.3. AIDS
6.2.1.4. Tuberculosis
6.2.1.5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
6.2.1.6. Hospital-Acquired Infections
6.2.1.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
6.2.1.8. Human Papillomavirus (HPV) Infection
6.2.1.9. Others
6.3. North America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Polymerase Chain Reaction (PCR)
6.3.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
6.3.1.3. Microarrays
6.3.1.4. Next-Generation Sequencing (NGS)
6.3.1.5. Hybridization
6.3.1.6. Others
6.4. North America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. Hospitals
6.4.1.2. Private Labs
6.4.1.3. Clinics
6.4.1.4. Academic Institutes
6.4.1.5. Laboratories
6.4.1.6. Others
6.5. North America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1. Key Highlights
6.5.1.1. U.S. Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.2. U.S. Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.3. U.S. Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.4. U.S. Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.5. Canada Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.6. Canada Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.7. Canada Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.8. Canada Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.2. BPS Analysis/Market Attractiveness Analysis
6.1.1. Key Highlights
6.1.1.1. Instruments and Analyzers
6.1.1.2. Assays and Reagents
6.1.1.3. Services and Software
6.2. North America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Hepatitis B
6.2.1.2. Hepatitis C
6.2.1.3. AIDS
6.2.1.4. Tuberculosis
6.2.1.5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
6.2.1.6. Hospital-Acquired Infections
6.2.1.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
6.2.1.8. Human Papillomavirus (HPV) Infection
6.2.1.9. Others
6.3. North America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Polymerase Chain Reaction (PCR)
6.3.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
6.3.1.3. Microarrays
6.3.1.4. Next-Generation Sequencing (NGS)
6.3.1.5. Hybridization
6.3.1.6. Others
6.4. North America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. Hospitals
6.4.1.2. Private Labs
6.4.1.3. Clinics
6.4.1.4. Academic Institutes
6.4.1.5. Laboratories
6.4.1.6. Others
6.5. North America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1. Key Highlights
6.5.1.1. U.S. Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.2. U.S. Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.3. U.S. Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.4. U.S. Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.5. Canada Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.6. Canada Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.7. Canada Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.1.8. Canada Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Europe Molecular Diagnostics in Infectious Disease Testing Market Outlook, 2018 - 2031
7.1. Europe Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Instruments and Analyzers
7.1.1.2. Assays and Reagents
7.1.1.3. Services and Software
7.2. Europe Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Hepatitis B
7.2.1.2. Hepatitis C
7.2.1.3. AIDS
7.2.1.4. Tuberculosis
7.2.1.5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
7.2.1.6. Hospital-Acquired Infections
7.2.1.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
7.2.1.8. Human Papillomavirus (HPV) Infection
7.2.1.9. Others
7.3. Europe Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Polymerase Chain Reaction (PCR)
7.3.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
7.3.1.3. Microarrays
7.3.1.4. Next-Generation Sequencing (NGS)
7.3.1.5. Hybridization
7.3.1.6. Others
7.4. Europe Molecular Diagnostics in Infectious Disease Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Hospitals
7.4.1.2. Private Labs
7.4.1.3. Clinics
7.4.1.4. Academic Institutes
7.4.1.5. Laboratories
7.4.1.6. Others
7.5. Europe Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1. Key Highlights
7.5.1.1. Germany Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.2. Germany Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.3. Germany Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.4. Germany Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.5. U.K. Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.6. U.K. Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.7. U.K. Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.8. U.K. Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.9. France Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.10. France Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.11. France Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.12. France Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.13. Italy Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.14. Italy Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.15. Italy Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.16. Italy Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.17. Turkey Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.18. Turkey Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.19. Turkey Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.20. Turkey Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.21. Russia Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.22. Russia Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.23. Russia Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.24. Russia Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.25. Rest of Europe Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.26. Rest of Europe Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.27. Rest of Europe Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.28. Rest of Europe Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.2. BPS Analysis/Market Attractiveness Analysis
7.1.1. Key Highlights
7.1.1.1. Instruments and Analyzers
7.1.1.2. Assays and Reagents
7.1.1.3. Services and Software
7.2. Europe Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Hepatitis B
7.2.1.2. Hepatitis C
7.2.1.3. AIDS
7.2.1.4. Tuberculosis
7.2.1.5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
7.2.1.6. Hospital-Acquired Infections
7.2.1.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
7.2.1.8. Human Papillomavirus (HPV) Infection
7.2.1.9. Others
7.3. Europe Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Polymerase Chain Reaction (PCR)
7.3.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
7.3.1.3. Microarrays
7.3.1.4. Next-Generation Sequencing (NGS)
7.3.1.5. Hybridization
7.3.1.6. Others
7.4. Europe Molecular Diagnostics in Infectious Disease Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Hospitals
7.4.1.2. Private Labs
7.4.1.3. Clinics
7.4.1.4. Academic Institutes
7.4.1.5. Laboratories
7.4.1.6. Others
7.5. Europe Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1. Key Highlights
7.5.1.1. Germany Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.2. Germany Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.3. Germany Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.4. Germany Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.5. U.K. Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.6. U.K. Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.7. U.K. Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.8. U.K. Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.9. France Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.10. France Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.11. France Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.12. France Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.13. Italy Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.14. Italy Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.15. Italy Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.16. Italy Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.17. Turkey Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.18. Turkey Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.19. Turkey Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.20. Turkey Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.21. Russia Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.22. Russia Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.23. Russia Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.24. Russia Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.25. Rest of Europe Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.26. Rest of Europe Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.27. Rest of Europe Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.1.28. Rest of Europe Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Outlook, 2018 - 2031
8.1. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Instruments and Analyzers
8.1.1.2. Assays and Reagents
8.1.1.3. Services and Software
8.2. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Hepatitis B
8.2.1.2. Hepatitis C
8.2.1.3. AIDS
8.2.1.4. Tuberculosis
8.2.1.5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
8.2.1.6. Hospital-Acquired Infections
8.2.1.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
8.2.1.8. Human Papillomavirus (HPV) Infection
8.2.1.9. Others
8.3. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Polymerase Chain Reaction (PCR)
8.3.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
8.3.1.3. Microarrays
8.3.1.4. Next-Generation Sequencing (NGS)
8.3.1.5. Hybridization
8.3.1.6. Others
8.4. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. Hospitals
8.4.1.2. Private Labs
8.4.1.3. Clinics
8.4.1.4. Academic Institutes
8.4.1.5. Laboratories
8.4.1.6. Others
8.5. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1. Key Highlights
8.5.1.1. China Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.2. China Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.3. China Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.4. China Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.5. Japan Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.6. Japan Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.7. Japan Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.8. Japan Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.9. South Korea Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.10. South Korea Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.11. South Korea Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.12. South Korea Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.13. India Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.14. India Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.15. India Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.16. India Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.17. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.18. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.19. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.20. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.21. Rest of Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.22. Rest of Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.23. Rest of Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.24. Rest of Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.2. BPS Analysis/Market Attractiveness Analysis
8.1.1. Key Highlights
8.1.1.1. Instruments and Analyzers
8.1.1.2. Assays and Reagents
8.1.1.3. Services and Software
8.2. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Hepatitis B
8.2.1.2. Hepatitis C
8.2.1.3. AIDS
8.2.1.4. Tuberculosis
8.2.1.5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
8.2.1.6. Hospital-Acquired Infections
8.2.1.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
8.2.1.8. Human Papillomavirus (HPV) Infection
8.2.1.9. Others
8.3. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Polymerase Chain Reaction (PCR)
8.3.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
8.3.1.3. Microarrays
8.3.1.4. Next-Generation Sequencing (NGS)
8.3.1.5. Hybridization
8.3.1.6. Others
8.4. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. Hospitals
8.4.1.2. Private Labs
8.4.1.3. Clinics
8.4.1.4. Academic Institutes
8.4.1.5. Laboratories
8.4.1.6. Others
8.5. Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1. Key Highlights
8.5.1.1. China Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.2. China Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.3. China Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.4. China Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.5. Japan Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.6. Japan Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.7. Japan Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.8. Japan Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.9. South Korea Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.10. South Korea Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.11. South Korea Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.12. South Korea Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.13. India Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.14. India Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.15. India Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.16. India Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.17. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.18. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.19. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.20. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.21. Rest of Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.22. Rest of Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.23. Rest of Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.1.24. Rest of Asia Pacific Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Latin America Molecular Diagnostics in Infectious Disease Testing Market Outlook, 2018 - 2031
9.1. Latin America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.1.1. Key Highlights
9.1.1.1. Instruments and Analyzers
9.1.1.2. Assays and Reagents
9.1.1.3. Services and Software
9.2. Latin America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.2.1. Key Highlights
9.2.1.1. Hepatitis B
9.2.1.2. Hepatitis C
9.2.1.3. AIDS
9.2.1.4. Tuberculosis
9.2.1.5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
9.2.1.6. Hospital-Acquired Infections
9.2.1.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
9.2.1.8. Human Papillomavirus (HPV) Infection
9.2.1.9. Others
9.3. Latin America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.3.1. Key Highlights
9.3.1.1. Polymerase Chain Reaction (PCR)
9.3.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
9.3.1.3. Microarrays
9.3.1.4. Next-Generation Sequencing (NGS)
9.3.1.5. Hybridization
9.3.1.6. Others
9.4. Latin America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1. Key Highlights
9.4.1.1. Hospitals
9.4.1.2. Private Labs
9.4.1.3. Clinics
9.4.1.4. Academic Institutes
9.4.1.5. Laboratories
9.4.1.6. Others
9.5. Latin America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1. Key Highlights
9.5.1.1. Brazil Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.2. Brazil Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.3. Brazil Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.4. Brazil Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.5. Mexico Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.6. Mexico Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.7. Mexico Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.8. Mexico Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.9. Argentina Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.10. Argentina Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.11. Argentina Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.12. Argentina Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.13. Rest of Latin America Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.14. Rest of Latin America Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.15. Rest of Latin America Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.16. Rest of Latin America Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.2. BPS Analysis/Market Attractiveness Analysis
9.1.1. Key Highlights
9.1.1.1. Instruments and Analyzers
9.1.1.2. Assays and Reagents
9.1.1.3. Services and Software
9.2. Latin America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.2.1. Key Highlights
9.2.1.1. Hepatitis B
9.2.1.2. Hepatitis C
9.2.1.3. AIDS
9.2.1.4. Tuberculosis
9.2.1.5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
9.2.1.6. Hospital-Acquired Infections
9.2.1.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
9.2.1.8. Human Papillomavirus (HPV) Infection
9.2.1.9. Others
9.3. Latin America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.3.1. Key Highlights
9.3.1.1. Polymerase Chain Reaction (PCR)
9.3.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
9.3.1.3. Microarrays
9.3.1.4. Next-Generation Sequencing (NGS)
9.3.1.5. Hybridization
9.3.1.6. Others
9.4. Latin America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.4.1. Key Highlights
9.4.1.1. Hospitals
9.4.1.2. Private Labs
9.4.1.3. Clinics
9.4.1.4. Academic Institutes
9.4.1.5. Laboratories
9.4.1.6. Others
9.5. Latin America Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1. Key Highlights
9.5.1.1. Brazil Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.2. Brazil Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.3. Brazil Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.4. Brazil Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.5. Mexico Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.6. Mexico Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.7. Mexico Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.8. Mexico Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.9. Argentina Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.10. Argentina Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.11. Argentina Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.12. Argentina Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.13. Rest of Latin America Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.14. Rest of Latin America Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.15. Rest of Latin America Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.1.16. Rest of Latin America Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
9.5.2. BPS Analysis/Market Attractiveness Analysis
10. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Outlook, 2018 - 2031
10.1. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.1.1. Key Highlights
10.1.1.1. Instruments and Analyzers
10.1.1.2. Assays and Reagents
10.1.1.3. Services and Software
10.2. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.2.1. Key Highlights
10.2.1.1. Hepatitis B
10.2.1.2. Hepatitis C
10.2.1.3. AIDS
10.2.1.4. Tuberculosis
10.2.1.5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
10.2.1.6. Hospital-Acquired Infections
10.2.1.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
10.2.1.8. Human Papillomavirus (HPV) Infection
10.2.1.9. Others
10.3. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.3.1. Key Highlights
10.3.1.1. Polymerase Chain Reaction (PCR)
10.3.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
10.3.1.3. Microarrays
10.3.1.4. Next-Generation Sequencing (NGS)
10.3.1.5. Hybridization
10.3.1.6. Others
10.4. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.4.1. Key Highlights
10.4.1.1. Hospitals
10.4.1.2. Private Labs
10.4.1.3. Clinics
10.4.1.4. Academic Institutes
10.4.1.5. Laboratories
10.4.1.6. Others
10.5. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1. Key Highlights
10.5.1.1. GCC Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.2. GCC Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.3. GCC Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.4. GCC Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.5. South Africa Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.6. South Africa Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.7. South Africa Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.8. South Africa Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.9. Egypt Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.10. Egypt Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.11. Egypt Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.12. Egypt Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.13. Nigeria Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.14. Nigeria Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.15. Nigeria Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.16. Nigeria Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.17. Rest of Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.18. Rest of Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.19. Rest of Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.20. Rest of Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.2. BPS Analysis/Market Attractiveness Analysis
10.1.1. Key Highlights
10.1.1.1. Instruments and Analyzers
10.1.1.2. Assays and Reagents
10.1.1.3. Services and Software
10.2. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.2.1. Key Highlights
10.2.1.1. Hepatitis B
10.2.1.2. Hepatitis C
10.2.1.3. AIDS
10.2.1.4. Tuberculosis
10.2.1.5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
10.2.1.6. Hospital-Acquired Infections
10.2.1.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
10.2.1.8. Human Papillomavirus (HPV) Infection
10.2.1.9. Others
10.3. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.3.1. Key Highlights
10.3.1.1. Polymerase Chain Reaction (PCR)
10.3.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
10.3.1.3. Microarrays
10.3.1.4. Next-Generation Sequencing (NGS)
10.3.1.5. Hybridization
10.3.1.6. Others
10.4. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.4.1. Key Highlights
10.4.1.1. Hospitals
10.4.1.2. Private Labs
10.4.1.3. Clinics
10.4.1.4. Academic Institutes
10.4.1.5. Laboratories
10.4.1.6. Others
10.5. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1. Key Highlights
10.5.1.1. GCC Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.2. GCC Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.3. GCC Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.4. GCC Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.5. South Africa Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.6. South Africa Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.7. South Africa Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.8. South Africa Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.9. Egypt Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.10. Egypt Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.11. Egypt Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.12. Egypt Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.13. Nigeria Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.14. Nigeria Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.15. Nigeria Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.16. Nigeria Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.17. Rest of Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.18. Rest of Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market by Application, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.19. Rest of Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market by Technique, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.1.20. Rest of Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
10.5.2. BPS Analysis/Market Attractiveness Analysis
11. Competitive Landscape
11.1. Technique vs Application Heatmap
11.2. Company Market Share Analysis, 2023
11.3. Competitive Dashboard
11.4. Company Profiles
11.4.1. Abbott Laboratories
11.4.1.1. Company Overview
11.4.1.2. Product Portfolio
11.4.1.3. Financial Overview
11.4.1.4. Business Strategies and Development
11.4.2. Becton
11.4.2.1. Company Overview
11.4.2.2. Product Portfolio
11.4.2.3. Financial Overview
11.4.2.4. Business Strategies and Development
11.4.3. Dickinson and Company
11.4.3.1. Company Overview
11.4.3.2. Product Portfolio
11.4.3.3. Financial Overview
11.4.3.4. Business Strategies and Development
11.4.4. bioMérieux
11.4.4.1. Company Overview
11.4.4.2. Product Portfolio
11.4.4.3. Financial Overview
11.4.4.4. Business Strategies and Development
11.4.5. Thermo Fisher Scientific Inc.
11.4.5.1. Company Overview
11.4.5.2. Product Portfolio
11.4.5.3. Financial Overview
11.4.5.4. Business Strategies and Development
11.4.6. F. Hoffmann-La Roche Ltd
11.4.6.1. Company Overview
11.4.6.2. Product Portfolio
11.4.6.3. Financial Overview
11.4.6.4. Business Strategies and Development
11.4.7. Siemens AG
11.4.7.1. Company Overview
11.4.7.2. Product Portfolio
11.4.7.3. Financial Overview
11.4.7.4. Business Strategies and Development
11.4.8. Veridex, LLC
11.4.8.1. Company Overview
11.4.8.2. Product Portfolio
11.4.8.3. Financial Overview
11.4.8.4. Business Strategies and Development
11.4.9. Luminex Corp.
11.4.9.1. Company Overview
11.4.9.2. Product Portfolio
11.4.9.3. Financial Overview
11.4.9.4. Business Strategies and Development
11.4.10. GenMark Diagnostics, Inc.
11.4.10.1. Company Overview
11.4.10.2. Product Portfolio
11.4.10.3. Financial Overview
11.4.10.4. Business Strategies and Development
11.4.11. Qiagen N.V.
11.4.11.1. Company Overview
11.4.11.2. Product Portfolio
11.4.11.3. Financial Overview
11.4.11.4. Business Strategies and Development
11.4.12. Genomix Biotech
11.4.12.1. Company Overview
11.4.12.2. Product Portfolio
11.4.12.3. Financial Overview
11.4.12.4. Business Strategies and Development
11.4.13. bioTheranostics
11.4.13.1. Company Overview
11.4.13.2. Product Portfolio
11.4.13.3. Financial Overview
11.4.13.4. Business Strategies and Development
11.2. Company Market Share Analysis, 2023
11.3. Competitive Dashboard
11.4. Company Profiles
11.4.1. Abbott Laboratories
11.4.1.1. Company Overview
11.4.1.2. Product Portfolio
11.4.1.3. Financial Overview
11.4.1.4. Business Strategies and Development
11.4.2. Becton
11.4.2.1. Company Overview
11.4.2.2. Product Portfolio
11.4.2.3. Financial Overview
11.4.2.4. Business Strategies and Development
11.4.3. Dickinson and Company
11.4.3.1. Company Overview
11.4.3.2. Product Portfolio
11.4.3.3. Financial Overview
11.4.3.4. Business Strategies and Development
11.4.4. bioMérieux
11.4.4.1. Company Overview
11.4.4.2. Product Portfolio
11.4.4.3. Financial Overview
11.4.4.4. Business Strategies and Development
11.4.5. Thermo Fisher Scientific Inc.
11.4.5.1. Company Overview
11.4.5.2. Product Portfolio
11.4.5.3. Financial Overview
11.4.5.4. Business Strategies and Development
11.4.6. F. Hoffmann-La Roche Ltd
11.4.6.1. Company Overview
11.4.6.2. Product Portfolio
11.4.6.3. Financial Overview
11.4.6.4. Business Strategies and Development
11.4.7. Siemens AG
11.4.7.1. Company Overview
11.4.7.2. Product Portfolio
11.4.7.3. Financial Overview
11.4.7.4. Business Strategies and Development
11.4.8. Veridex, LLC
11.4.8.1. Company Overview
11.4.8.2. Product Portfolio
11.4.8.3. Financial Overview
11.4.8.4. Business Strategies and Development
11.4.9. Luminex Corp.
11.4.9.1. Company Overview
11.4.9.2. Product Portfolio
11.4.9.3. Financial Overview
11.4.9.4. Business Strategies and Development
11.4.10. GenMark Diagnostics, Inc.
11.4.10.1. Company Overview
11.4.10.2. Product Portfolio
11.4.10.3. Financial Overview
11.4.10.4. Business Strategies and Development
11.4.11. Qiagen N.V.
11.4.11.1. Company Overview
11.4.11.2. Product Portfolio
11.4.11.3. Financial Overview
11.4.11.4. Business Strategies and Development
11.4.12. Genomix Biotech
11.4.12.1. Company Overview
11.4.12.2. Product Portfolio
11.4.12.3. Financial Overview
11.4.12.4. Business Strategies and Development
11.4.13. bioTheranostics
11.4.13.1. Company Overview
11.4.13.2. Product Portfolio
11.4.13.3. Financial Overview
11.4.13.4. Business Strategies and Development
12. Appendix
12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations
12.2. Report Assumptions
12.3. Acronyms and Abbreviations
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Becton
- Dickinson and Company
- bioMérieux
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche Ltd
- Siemens AG
- Veridex, LLC
- Luminex Corp.
- GenMark Diagnostics, Inc.
- Qiagen N.V.
- Genomix Biotech
- bioTheranostics
Methodology
LOADING...
